Showing 361-370 of 1319 results for "".
MS Minute: Mood Disorders and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-mood-disorders-and-multiple-sclerosis/32076/Individuals with MS are at twice the risk of suicide than the general population, so it’s vital for clinicians to screen for depression and to provide various treatment options.Therapeutic Hypothermia Effects on Brain Development
https://practicalneurology.com/diseases-diagnoses/child-neurology/therapeutic-hypothermia-effects-on-brain-development/31641/Therapeutic hypothermia has proven neuroprotective effects for neonates but they remain a high-risk group with continued need for neurodevelopmental screening.Immune Checkpoint Inhibitor Neuromuscular Complications
https://practicalneurology.com/diseases-diagnoses/neuromuscular/immune-checkpoint-inhibitor-neuromuscular-complications/31922/Team-based approaches are needed to manage and better understand the adverse events of immune checkpoint inhibitors.Neuroimaging Traumatic Brain Injuries
https://practicalneurology.com/diseases-diagnoses/tbi/neuroimaging-traumatic-brain-injuries/31599/Imaging is of paramount importance to the overall care of people with TBIsGenetic Testing in Adults with Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/genetic-testing-in-adults-with-epilepsy/32052/Appropriate treatment of adults with epilepsy requires the practitioner to be familiar with indications for genetic testing, approaches to testing, diagnostic yield, and clinical ramifications of the results.Novel Lipid-Lowering Agents and Stroke Prevention:
New Tools, New Targetshttps://practicalneurology.com/diseases-diagnoses/stroke/novel-lipid-lowering-agents-and-stroke-preventionbrnew-tools-new-targets/32074/Established and novel lipid-lowering agents offer increasing opportunities to achieve effective primary and secondary stroke prevention.Clinical Use of Alzheimer Disease Biomarkers: Legal, Ethical, and Social Considerations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-alzheimer-disease-biomarkers-legal-ethical-and-social-considerations/32141/Legal, ethical, and social considerations are emerging along with the clinical implementation of Alzheimer disease biomarkers.Special Report: Cognitive Screening After COVID-19
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/special-report-cognitive-screening-after-covid-19/31791/Tools are needed for the assessment of neurologic and neuropsychologic sequelae of infection with the SARS-CoV-2 virus.Atrial Cardiopathy and Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/atrial-cardiopathy-and-stroke/31614/The past decade there has been a resurgence in understanding of the relationship of atrial fibrillation to stroke.Therapeutic Approaches to Neuromuscular Repeat Disorders: Facioscapulohumeral Muscular Dystrophy and Myotonic Dystrophy Type 1
https://practicalneurology.com/diseases-diagnoses/neuromuscular/therapeutic-approaches-to-neuromuscular-repeat-disorders-facioscapulohumeral-muscular-dystrophy-and-myotonic-dystrophy-type-1/32027/A promising pipeline of therapeutics target toxic RNA.